Microbial Diseases A to Z | Disease Home Page | Bio 406 Home Page | MicroWorld

Viral Hemorrhagic Fever

Introduction. 

Viral hemorrhagic fevers (VHF) are among the scariest of viral diseases due to their dramatic symptoms, rapid time course, high mortality rate and lack of effective treatment. VHF have been dramatized in movies such as Outbreak and books such as The Hot Zone that describe the Ebola virus. However, numerous other hemorrhagic viruses exist, including Junin, Machupo, Guanarito, Sabia, Crimean-Congo, Lassa, Dengue, Yellow fever, Chapare, Marburg, Hanta, and Rift Valley. Many of these cause a disease syndrome accompanied by fever and multi-organ system failure which can lead to death.

The Pathogens

VHF viruses fall into 4 major virus families: Arenaviruses, Bunyaviruses, Flaviviruses and Filoviruses.

Virus Family Disease Distribution Transmission
Ebola Filovirus Ebola Africa DC
Marburg Filovirus Marburg HF Africa DC
Dengue fever virus Flavivirus Dengue HF Africa Vector
Yellow fever Flavivirus Yellow fever Africa Vector
Sin Nombre virus Bunyavirus Hantavirus Pulmonary syndrome US DC, inhalation
Hantaan virus Bunyavirus HFRS Asia DC, inhalation
Nairovirus Bunyavirus Crimean Congo HF Africa Vector
Phlebovirus Bunyavirus Rift Valley fever Africa Vector
Lassa virus Arenavirus Lassa HF Africa DC, inhalation
Junin virus Arenavirus Argentine HF South America DC, inhalation
Machupo virus Arenavirus Bolivian HF South America DC, inhalation
Guanarito virus Arenavirus Venezuelan HF South America DC, inhalation
Sabia virus Arenavirus Brazilian HF South America DC, inhalation
Chapare virus Arenavirus Chapare HF South America DC, inhalation

Symptoms/Pathogenesis

Initial symptoms may be mild or severe, but usually include fever and malaise. Headaches, nausea, vomiting, liver damage and myalgia may follow. VHFs feature bleeding (both internal and external) that may be intestinal, respiratory, or from the eyes, often caused by damage to the vascular endothelium.

Diagnosis

Differentiation of VHFs relies largely on patient history, e.g. contact with infected individuals (Ebola), animals (Hanta, Marburg), vectors (Crimean Congo, Dengue), and/or particular geographical locations. Specialized laboratory diagnosis may be necessary and include electron microscopy, antigen-based tests, genetic analysis or even viral culture. Because of the seriousness of VHF, such testing can usually only be done in BSL-4 labs.

Treatment/Prevention

Few treatments exist for VHFs other than supportive care. Rehydration and cardiovascular support can help counter blood loss, but ultimately viral damage to internal organs causes more damage than hemorrhaging alone. Ribavirin (Lassa) and some experimental drugs (Ebola) have been used with limited success. Prevention efforts are also limited to limiting contact with reservoir animals and vectors, as a vaccine exists for only one VHF (Yellow Fever).

References/Links

  1. http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/vhf.htm
  2. https://jvi.asm.org/content/85/2/835
  3.